Dynamic characteristics of blood glucose time series during the course of critical illness: effects of intensive insulin therapy and relative association with mortality
- PMID: 20124887
- DOI: 10.1097/CCM.0b013e3181cf710e
Dynamic characteristics of blood glucose time series during the course of critical illness: effects of intensive insulin therapy and relative association with mortality
Abstract
Objectives: To assess the effect of intensive insulin therapy on blood glucose amplitude variation and pattern irregularity in critically ill patients. To assess the association of these blood glucose signal characteristics with hospital mortality, independent of blood glucose level.
Design: Retrospective analysis of the databases of two previously published randomized controlled trials.
Setting: University hospital, 56-bed adult surgical intensive care unit and 17-bed medical intensive care unit.
Patients: One thousand five-hundred forty-eight surgical intensive care unit patients, admitted between February 2000 and January 2001, and 1200 medical intensive care unit patients, admitted between March 2002 and May 2005.
Interventions: In the two randomized controlled trials, patients were randomized to receive either intensive insulin therapy (targeting normoglycemia, between 4.4 and 6.1 mmol/L) or conventional insulin therapy (infusing insulin when blood glucose levels were >12 mmol/L and stopping at 10 mmol/L).
Measurements and main results: Intensive insulin therapy significantly lowered mean blood glucose (5.8 vs. 8.4 mmol/L), hyperglycemic index (0.8 vs. 3.2 mmol/L), and glycemic penalty index (26 vs. 53), but it increased the mean daily difference between minimum and maximum blood glucose (mean daily delta blood glucose; 4.0 vs. 3.3 mmol/L). There was no significant effect on the standard deviation of the blood glucose measurements or on jack-knifed approximate entropy. In multivariable logistic regression analysis, corrected for baseline risk factors, blood glucose levels outside the normoglycemic range, higher mean daily delta blood glucose, higher standard deviation blood glucose, and higher jack-knifed approximate entropy were independently associated with hospital mortality.
Conclusions: The Leuven intensive insulin therapy strategy increased mean daily delta blood glucose while not affecting standard deviation blood glucose and jack-knifed approximate entropy. Increased blood glucose amplitude variation and pattern irregularity were associated with mortality, irrespective of blood glucose level. The reduced mortality observed with intensive insulin therapy in the Leuven trials cannot be attributed to an effect on blood glucose amplitude variation or entropy. Reducing amplitude variation and entropy of the blood glucose signal, irrespective of blood glucose concentration, may produce clinical benefits.
Comment in
-
Glycemic variability in critical illness and the end of Chapter 1.Crit Care Med. 2010 Apr;38(4):1206-8. doi: 10.1097/CCM.0b013e3181d3aba5. Crit Care Med. 2010. PMID: 20335697 No abstract available.
-
Parenteral feeding and intensive insulin therapy.Crit Care Med. 2010 Sep;38(9):1922; author reply 1922-3. doi: 10.1097/CCM.0b013e3181e4b637. Crit Care Med. 2010. PMID: 20724900 No abstract available.
Similar articles
-
Blood glucose concentration and outcome of critical illness: the impact of diabetes.Crit Care Med. 2008 Aug;36(8):2249-55. doi: 10.1097/CCM.0b013e318181039a. Crit Care Med. 2008. PMID: 18664780
-
Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control.Crit Care Med. 2003 Feb;31(2):359-66. doi: 10.1097/01.CCM.0000045568.12881.10. Crit Care Med. 2003. PMID: 12576937 Clinical Trial.
-
Glucose control in the intensive care unit.Crit Care Med. 2009 May;37(5):1769-76. doi: 10.1097/CCM.0b013e3181a19ceb. Crit Care Med. 2009. PMID: 19325461 Review.
-
Lowering of glucose in critical care: a randomized pilot trial.J Crit Care. 2007 Jun;22(2):112-8; discussion 118-9. doi: 10.1016/j.jcrc.2006.08.002. Epub 2007 Jan 31. J Crit Care. 2007. PMID: 17548021 Clinical Trial.
-
Blood glucose control in the intensive care unit: benefits and risks.Semin Dial. 2010 Mar-Apr;23(2):157-62. doi: 10.1111/j.1525-139X.2010.00702.x. Semin Dial. 2010. PMID: 20525106 Review.
Cited by
-
The effect of diabetes mellitus on the association between measures of glycaemic control and ICU mortality: a retrospective cohort study.Crit Care. 2013 Mar 19;17(2):R52. doi: 10.1186/cc12572. Crit Care. 2013. PMID: 23510051 Free PMC article.
-
Glycemic control in the critically ill - 3 domains and diabetic status means one size does not fit all!Crit Care. 2013 Apr 17;17(2):131. doi: 10.1186/cc12584. Crit Care. 2013. PMID: 23594397 Free PMC article.
-
Critical Care Management of Stress-Induced Hyperglycemia.Curr Diab Rep. 2018 Feb 26;18(4):17. doi: 10.1007/s11892-018-0988-2. Curr Diab Rep. 2018. PMID: 29479638 Review.
-
Mild hypoglycemia is strongly associated with increased intensive care unit length of stay.Ann Intensive Care. 2011 Nov 24;1:49. doi: 10.1186/2110-5820-1-49. Ann Intensive Care. 2011. PMID: 22115519 Free PMC article.
-
Diabetic status and the relation of the three domains of glycemic control to mortality in critically ill patients: an international multicenter cohort study.Crit Care. 2013 Mar 1;17(2):R37. doi: 10.1186/cc12547. Crit Care. 2013. PMID: 23452622 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical